News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biolipox AB Reports Rapid Relief With NLA Nasal Spray In New Clinical Trial


10/19/2005 5:12:48 PM

STOCKHOLM, Sweden, Feb. 22, 2005 (PRIMEZONE) -- Biolipox, a Swedish research-intensive pharmaceutical company in respiratory and inflammatory diseases, announced today that it has successfully completed a new clinical study, evaluating the time-to-onset of effect of its new antihistamine treatment, NLA Nasal Spray. The drug was shown to have an onset of effect within 5-10 minutes after intake. This follows the announcement in June 2004 that NLA Nasal Spray had reached the primary efficacy endpoint of a Phase IIa study in patients suffering from allergic rhinitis. These results strongly support the development of NLA Nasal Spray as on-demand treatment.

Read at Prime Zone

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES